BackAMGEN Overview
AMGEN Inc.

AMGEN Target Price

Analysts' average 12-month price target for AMGEN is $370.

Get informed when a big investor buys or sells

+ Follow

Share Price

$419.38

Average Target Price

$372.8611.1% downside

21 analysts in the last 4 months

High: $450 | Low: $230

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-14BarclaysEmily Field$3809.4% downsideOpen
2026-08-10GuggenheimVamil Divan$3887.5% downsideOpen
2026-08-06Bernstein$34517.7% downsideOpen
2026-08-05Robert W. BairdBrian Skorney$23045.2% downsideOpen
2026-08-05ScotiabankLouise Chen$4507.3% upsideOpen
2026-08-05RBC Capital$4004.6% downsideOpen
2026-08-05BMO CapitalEvan Seigerman$4507.3% upsideOpen
2026-08-05Canaccord GenuityGary Nachman$3848.4% downsideOpen
2026-08-05Oppenheimer$4507.3% upsideOpen
2026-07-29BarclaysEmily Field$36014.2% downsideOpen
2026-07-13UBS$4200.1% upsideOpen
2026-07-13Guggenheim$34318.2% downsideOpen
2026-07-08Morgan Stanley$33320.6% downsideOpen
2026-07-01BMO CapitalEvan David Seigerman$4004.6% downsideOpen
2026-06-16Mizuho SecuritiesSalim Syed$30327.8% downsideOpen
2026-06-09Morgan Stanley$34018.9% downsideOpen
2026-06-05Goldman Sachs$3897.2% downsideOpen
2026-05-14Piper Sandler$4271.8% upsideOpen
2026-05-04Guggenheim$34018.9% downsideOpen
2026-05-01Morgan Stanley$33220.8% downsideOpen
2026-04-20Canaccord Genuity$36612.7% downsideOpen
2026-04-10Morgan StanleyTerence Flynn$32622.3% downsideOpen
2026-04-09Guggenheim$35116.3% downsideOpen
2026-04-08Truist Financial$32522.5% downsideOpen
2026-03-10JefferiesAkash Tewari$35016.5% downsideOpen
2026-03-05Leerink PartnersDavid Risinger$35515.4% downsideOpen
2026-02-19Barclays$18555.9% downsideOpen
2026-02-19Wells Fargo$37510.6% downsideOpen
2026-02-18Piper Sandler$4323% upsideOpen
2026-02-11Mizuho Securities$29529.7% downsideOpen
2026-02-04Morgan Stanley$30926.3% downsideOpen
2026-02-04RBC Capital$36014.2% downsideOpen
2026-01-29Oppenheimer$4004.6% downsideOpen
2026-01-26UBS$3907% downsideOpen
2026-01-20BernsteinMarket Perform$33520.1% downsideOpen
2026-01-06UBS$3809.4% downsideOpen
2025-12-12Morgan Stanley$30427.5% downsideOpen
2025-12-10HSBC$4251.3% upsideOpen
2025-12-03BMO CapitalEvan Seigerman$37211.3% downsideOpen
2025-11-25Wells Fargo$4004.6% downsideOpen
2025-11-24Truist Financial$31824.2% downsideOpen
2025-11-14Piper SandlerDavid Amsellem$3819.2% downsideOpen
2025-11-06Cantor Fitzgerald$31524.9% downsideOpen
2025-11-05Wells Fargo$30028.5% downsideOpen
2025-08-25Piper Sandler$34218.5% downsideOpen
2025-05-02UBSTrung Huynh$31524.9% downsideOpen
2025-04-22Cantor Fitzgerald$30527.3% downsideOpen
2025-03-05Johnson Rice$29429.9% downsideOpen
2024-11-12Cantor FitzgeraldOlivia Brayer$4053.4% downsideOpen
2024-11-12JefferiesMichael Yee$3809.4% downsideOpen

AMGEN (AMGN) FAQ

AMGEN (AMGN) currently reports a target price of $370. Use the charts on this page to explore AMGEN's target price history and peer comparisons.

Analysts' average 12-month price target for AMGEN is $370, about 11.1% downside from the current share price of $419.38. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $370, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AMGEN, and consider following AMGN for alerts when major investors trade the stock.

AMGEN is classified in the Healthcare sector. On target price, it currently shows $370. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMGN with unrelated industries.